BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 29687298)

  • 1. The 2017 WHO classification of pituitary adenoma: overview and comments.
    Inoshita N; Nishioka H
    Brain Tumor Pathol; 2018 Apr; 35(2):51-56. PubMed ID: 29687298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New WHO classification of pituitary adenomas (4th edition): assessment of pituitary transcription factors and the prognostic histological factors.
    Nishioka H; Inoshita N
    Brain Tumor Pathol; 2018 Apr; 35(2):57-61. PubMed ID: 29318396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newer Concepts in the Classification of Pituitary Adenomas.
    Sathyakumar R; Chacko G
    Neurol India; 2020; 68(Supplement):S7-S12. PubMed ID: 32611886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of the 2017 WHO Classification of Pituitary Tumors.
    Mete O; Lopes MB
    Endocr Pathol; 2017 Sep; 28(3):228-243. PubMed ID: 28766057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 2017 World Health Organization classification of tumors of the pituitary gland: a summary.
    Lopes MBS
    Acta Neuropathol; 2017 Oct; 134(4):521-535. PubMed ID: 28821944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular, functional, and histopathological classification of the pituitary neuroendocrine neoplasms.
    Inomoto C; Tahara S; Oyama K; Kimura M; Matsuno A; Teramoto A; Osamura RY
    Brain Tumor Pathol; 2021 Jul; 38(3):183-188. PubMed ID: 34269950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. World Health Ozganization 2017 Classification of Pituitary Tumors.
    Lopes MBS
    Endocrinol Metab Clin North Am; 2020 Sep; 49(3):375-386. PubMed ID: 32741477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Histopathological and Genetic Parameters of Pituitary Adenomas: Clinical Impact and Recommendation for Future WHO Classification.
    Saeger W; Petersenn S; Schöfl C; Knappe UJ; Theodoropoulou M; Buslei R; Honegger J
    Endocr Pathol; 2016 Jun; 27(2):115-22. PubMed ID: 26874696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposal of a clinically relevant working classification of pituitary neuroendocrine tumors based on pituitary transcription factors.
    Silva-Ortega S; García-Martinez A; Niveiro de Jaime M; Torregrosa ME; Abarca J; Monjas I; Picó Alfonso A; Aranda López I
    Hum Pathol; 2021 Apr; 110():20-30. PubMed ID: 33321163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Implications of the New WHO Classification 2017 for Pituitary Tumors.
    Saeger W; Koch A
    Exp Clin Endocrinol Diabetes; 2021 Mar; 129(3):146-156. PubMed ID: 33690870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of additional transcription factors is of prognostic value for aggressive behavior of pituitary adenomas.
    Micko A; Rötzer T; Hoftberger R; Vila G; Oberndorfer J; Frischer JM; Knosp E; Wolfsberger S
    J Neurosurg; 2020 Apr; 134(3):1139-1146. PubMed ID: 32302984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of the 2022 WHO Classification of Pituitary Tumors.
    Asa SL; Mete O; Perry A; Osamura RY
    Endocr Pathol; 2022 Mar; 33(1):6-26. PubMed ID: 35291028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Impact of the Current WHO Classification of Pituitary Adenomas.
    Saeger W; Honegger J; Theodoropoulou M; Knappe UJ; Schöfl C; Petersenn S; Buslei R
    Endocr Pathol; 2016 Jun; 27(2):104-14. PubMed ID: 26860936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of T-box Transcription Factor in a Pituitary Adenoma Diagnostic Algorithm.
    McDonald WC; McDonald KN; Helmer JA; Ho B; Wang A; Banerji N
    Arch Pathol Lab Med; 2021 May; 145(5):592-598. PubMed ID: 32991684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Morphofunctional features of non-functioning pituitary adenomas].
    Eremkina AK; Dzeranova LK; Pigarova EK; Mokrysheva NG; Dedov II
    Arkh Patol; 2019; 81(1):71-78. PubMed ID: 30830109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plurihormonal pituitary adenomas: immunostaining of all pituitary hormones is mandatory for correct classification.
    Ho DM; Hsu CY; Ting LT; Chiang H
    Histopathology; 2001 Sep; 39(3):310-9. PubMed ID: 11532042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry.
    Saeger W; Lüdecke DK; Buchfelder M; Fahlbusch R; Quabbe HJ; Petersenn S
    Eur J Endocrinol; 2007 Feb; 156(2):203-16. PubMed ID: 17287410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification and pathology of pituitary tumors.
    Kontogeorgos G
    Endocrine; 2005 Oct; 28(1):27-35. PubMed ID: 16311407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Classification and pathophysiology of pituitary adenomas].
    Galland F; Chanson P
    Bull Acad Natl Med; 2009 Oct; 193(7):1543-56; discussion 1556. PubMed ID: 20669635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current pathological classification of pituitary adenomas.
    Saeger W
    Acta Neurochir Suppl; 1996; 65():1-3. PubMed ID: 8738481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.